RELATED CONTENT
NEWS
- INTERVIEW: ADDF optimistic on Alzheimer's drugs despite recent setbacks
- GE provides Merck with imaging agent for Alzheimer's drug trial
- New study's big ask: Can amyloid clearing drugs halt Alzheimer's in high-risk patients?
- Lilly EXPEDITION data puts some flesh on solanezumab's bones

